Kusha Davar

1.2k total citations
13 papers, 184 citations indexed

About

Kusha Davar is a scholar working on Epidemiology, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, Kusha Davar has authored 13 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Clinical Biochemistry and 3 papers in Infectious Diseases. Recurrent topics in Kusha Davar's work include Bacterial Identification and Susceptibility Testing (4 papers), Antibiotic Use and Resistance (3 papers) and Infective Endocarditis Diagnosis and Management (3 papers). Kusha Davar is often cited by papers focused on Bacterial Identification and Susceptibility Testing (4 papers), Antibiotic Use and Resistance (3 papers) and Infective Endocarditis Diagnosis and Management (3 papers). Kusha Davar collaborates with scholars based in United States, Canada and Switzerland. Kusha Davar's co-authors include Mika Watanabe, Christopher J. Graber, Matthew Bidwell Goetz, Lauren P. Jatt, Alexander Viloria Winnett, Brad Spellberg, Fernándo Domínguez, Matthew C. Phillips, Rachael Lee and Noah Wald‐Dickler and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Tropical Medicine and Hygiene and Clinical Microbiology and Infection.

In The Last Decade

Kusha Davar

11 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kusha Davar United States 5 70 48 48 31 27 13 184
Hilary Placzek United States 11 61 0.9× 109 2.3× 90 1.9× 23 0.7× 14 0.5× 16 314
Costanza Vicentini Italy 11 95 1.4× 59 1.2× 82 1.7× 76 2.5× 34 1.3× 47 351
Christelle Elias France 9 96 1.4× 19 0.4× 81 1.7× 35 1.1× 39 1.4× 19 223
Jasmin Islam United Kingdom 10 140 2.0× 55 1.1× 66 1.4× 104 3.4× 54 2.0× 21 315
Kwee Yuen Tan Singapore 7 87 1.2× 16 0.3× 54 1.1× 46 1.5× 31 1.1× 12 270
Valerie M. Deloney United States 7 55 0.8× 41 0.9× 37 0.8× 36 1.2× 6 0.2× 14 142
Alyssa R. Letourneau United States 8 62 0.9× 22 0.5× 82 1.7× 15 0.5× 7 0.3× 28 224
Marion Le Maréchal France 10 144 2.1× 45 0.9× 135 2.8× 70 2.3× 10 0.4× 33 341
Federica Calò Italy 10 80 1.1× 15 0.3× 77 1.6× 42 1.4× 13 0.5× 21 242
Olisaeloka Nsonwu United Kingdom 7 72 1.0× 23 0.5× 46 1.0× 49 1.6× 26 1.0× 18 181

Countries citing papers authored by Kusha Davar

Since Specialization
Citations

This map shows the geographic impact of Kusha Davar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kusha Davar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kusha Davar more than expected).

Fields of papers citing papers by Kusha Davar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kusha Davar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kusha Davar. The network helps show where Kusha Davar may publish in the future.

Co-authorship network of co-authors of Kusha Davar

This figure shows the co-authorship network connecting the top 25 collaborators of Kusha Davar. A scholar is included among the top collaborators of Kusha Davar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kusha Davar. Kusha Davar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Prosty, Connor, Rachel Baden, Kusha Davar, et al.. (2025). Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis. JAMA Internal Medicine. 185(10). 1194–1194. 1 indexed citations
2.
Canamar, Catherine P., et al.. (2025). Interpreting Blood Culture Results as Early Guidance for Infective Endocarditis. JAMA Network Open. 8(5). e258079–e258079. 1 indexed citations
3.
Davar, Kusha, et al.. (2024). Outpatient Oral Doxycycline Therapy for Ocular Syphilis. JAMA Network Open. 7(12). e2449364–e2449364. 2 indexed citations
4.
Wald‐Dickler, Noah, Catherine P. Canamar, Kusha Davar, et al.. (2023). Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study. Clinical Infectious Diseases. 77(5). 672–679. 33 indexed citations
5.
Davar, Kusha & Tara Vijayan. (2023). The PEST (Pathology, Epidemiology, Severity, Treatment) approach to optimizing antimicrobial therapy. BMC Medical Education. 23(1). 316–316. 1 indexed citations
6.
Phillips, Matthew C., Noah Wald‐Dickler, Kusha Davar, et al.. (2023). Choosing patients over placebos: oral transitional therapy vs. IV-only therapy for bacteraemia and infective endocarditis. Clinical Microbiology and Infection. 29(9). 1126–1132. 6 indexed citations
7.
Davar, Kusha, et al.. (2023). Case Report: Cardiovascular Manifestations due to Flea-Borne Typhus. American Journal of Tropical Medicine and Hygiene. 110(1). 150–154. 1 indexed citations
8.
Domínguez, Fernándo, Kusha Davar, Noah Wald‐Dickler, et al.. (2022). How to change the course: practical aspects of implementing shorter is better. Clinical Microbiology and Infection. 29(11). 1402–1406. 4 indexed citations
9.
Davar, Kusha, Devin Clark, Robert M. Centor, et al.. (2022). Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV. Open Forum Infectious Diseases. 10(1). ofac706–ofac706. 36 indexed citations
10.
Davar, Kusha, Michael R. Wilson, Steve Miller, Charles Y. Chiu, & Tara Vijayan. (2021). A Rare Bird: Diagnosis of Psittacosis Meningitis by Clinical Metagenomic Next-Generation Sequencing. Open Forum Infectious Diseases. 8(12). ofab555–ofab555. 4 indexed citations
11.
Price, Travis K., Kusha Davar, Deisy Contreras, et al.. (2021). Case Report and Genomic Analysis of Cefiderocol-Resistant Escherichia coli Clinical Isolates. American Journal of Clinical Pathology. 157(2). 257–265. 11 indexed citations
12.
Winnett, Alexander Viloria, Lauren P. Jatt, Kusha Davar, et al.. (2020). Universal and Serial Laboratory Testing for SARS-CoV-2 at a Long-Term Care Skilled Nursing Facility for Veterans — Los Angeles, California, 2020. MMWR Morbidity and Mortality Weekly Report. 69(21). 651–655. 84 indexed citations
13.
Davar, Kusha, et al.. (2016). Disseminated Cryptococcosis with Endobronchial Lesions.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilary Placzek Breakdown of academic impact, for papers by Costanza Vicentini Breakdown of academic impact, for papers by Christelle Elias Breakdown of academic impact, for papers by Jasmin Islam Breakdown of academic impact, for papers by Kwee Yuen Tan Breakdown of academic impact, for papers by Valerie M. Deloney Breakdown of academic impact, for papers by Alyssa R. Letourneau Breakdown of academic impact, for papers by Marion Le Maréchal Breakdown of academic impact, for papers by Federica Calò Breakdown of academic impact, for papers by Olisaeloka Nsonwu
Rankless by CCL
2026